Clinical evidence demonstrates that resistance exercise does not interact negatively with semaglutide therapy and may actually enhance weight loss outcomes
They complain of dizziness and nausea and fall asleep at their desks
Topline results from a Phase 3b trial in the global STEP program demonstrated statistically significant and superior weight loss at 72 weeks with semaglutide 7.2 mg, compared with placebo, irrespective of treatment adherence
doi: 10.3389/fimmu.2021.757967 52 ZhouL
Bellastella G, Maiorino MI, Longo M, Scappaticcio L, Chiodini P, Esposito K, et al
Symptoms include blurred or warped vision, vision loss and new floaters